Pharmacology and Obesity Treatment
Moving in BMJ, JAMA, New England Journal of Medicine.
- Moved this week
- 3
Rebuilt
Moved this week
Once-weekly survodutide significantly reduces body weight by approximately 12-13% in adults with obesity without diabetes, outperforming placebo in a phase 3 trial.
- Open access
- 18 cites
Drugs for overweight or obesity achieve up to 14.9% weight loss at one year but vary in benefits and harms, with some also reducing cardiovascular risks.
- Open access
- 5 cites
Latest in Pharmacology and Obesity Treatment
Newest first · last 60 days
Effective obesity treatments, including new medications and procedures, are available but have not significantly reduced obesity rates in the US, which remain stable.
A very-low-carbohydrate diet yields 2-3 times greater improvements in hepatic insulin sensitivity than Mediterranean or very-low-fat diets during 10% weight loss in metabolically unhealthy obesity.
Once-weekly survodutide significantly reduces body weight by approximately 12-13% in adults with obesity without diabetes, outperforming placebo in a phase 3 trial.
- Open access
- 18 cites
Follow this area in the app
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res483
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ199
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- J Exp Bot115
- Curr Biol112
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4